Ergoteles’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,511
| Closed | -$1.21M | – | 92 |
|
|
2023
Q2 | $1.21M | Buy |
13,511
+6,749
| +100% | +$602K | 0.06% | 416 |
|
|
2023
Q1 | $725K | Buy |
6,762
+2,095
| +45% | +$225K | 0.03% | 612 |
|
|
2022
Q4 | $570K | Buy |
4,667
+2,232
| +92% | +$273K | 0.02% | 649 |
|
|
2022
Q3 | $251K | Buy |
2,435
+194
| +9% | +$20K | 0.01% | 1070 |
|
|
2022
Q2 | $208K | Buy |
+2,241
| New | +$208K | 0.01% | 1303 |
|
|
2022
Q1 | – | Sell |
-13,165
| Closed | -$1.77M | – | 1202 |
|
|
2021
Q4 | $1.77M | Buy |
+13,165
| New | +$1.77M | 0.07% | 276 |
|
|
2021
Q2 | – | Sell |
-18,547
| Closed | -$2.39M | – | 1481 |
|
|
2021
Q1 | $2.39M | Buy |
+18,547
| New | +$2.39M | 0.07% | 256 |
|